Article2021
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies
Theodoros P. Vassilakopoulos, Sotirios G. Papageorgiou, Maria K. Angelopoulou, Sophia Chatziioannou, Vassilios Prassopoulos, Stamatis Karakatsanis, Maria Arapaki, Zois Mellios, Sotirios Sachanas, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ιoannis Kotsianidis, Eleftheria Hatzimichael, Maria Kotsopoulou, Maria Dimou, Eleni Variamis, Dimitrios Boutsis, Evangelos Terpos, Evridiki Michali, George Karianakis, Pantelis Tsirkinidis,
Article2022
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma
Stamatis Karakatsanis, Maria Bouzani, Argiris Symeonidis, Maria K. Angelopoulou, Sotirios G. Papageorgiou, Michail Michail, Gabriella Gainaru, Georgia Kourti, Sotirios Sachanas, Christina Kalpadakis, Eirini Katodritou, Theoni Leonidopoulou, Ιoannis Kotsianidis, Eleftheria Hatzimichael, Maria Kotsopoulou, Maria Dimou, Eleni Variamis, Dimitrios Boutsis, N. Kanellias, Maria Dimopoulou, Evridiki Michali, George Karianakis, Pantelis Tsirkinidis, ,
Discussion(0)
No comments yet. Be the first to comment.